Messages of Hope
FNIH Announces Neurofilament Project Designed to Improve Diagnostic Process for Familial FTD
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium, in partnership with AFTD, recently launched a new project designed for early detection of hereditary forms of FTD and…
Read MoreAFTD Ambassador Advocates for Dementia Care Management Legislation in “News & Observer” Editorial
AFTD Ambassador Dr. Gerald Lazarus wrote a guest editorial for the North Carolina-based newspaper The News & Observer advocating for local politicians to support a proposed legislative measure that aims…
Read MoreMessages of Hope
Rare Disease Day 2022: Think FTD
February 28 marks Rare Disease Day, an annual campaign intended to increase awareness of rare diseases and their impact on individuals and families. While FTD is classified as a rare disease,…
Read MoreArkuda Therapeutics Secures Funding for FTD-GRN Research
Biotechnology company Arkuda Therapeutics recently acquired multi-million dollar funding to continue its research program targeted at increasing progranulin protein production in persons diagnosed with FTD-GRN. Researchers at Arkuda are continuing…
Read More
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)